Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Recce Pharmaceuticals Ltd. announced a change in the interests of Director Dr. John Prendergast, who acquired 2,650,000 unlisted options under the company’s Employee Incentive Plan. These options have an estimated value of $0.244 each, calculated using the Black Scholes valuation method, highlighting the director’s increased stake in the company.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.
